BC
IMMU

Brinker Capital’s Immunomedics Inc IMMU Stock Holding History

Brinker Capital’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$2.66M Buy
75,052
+6,452
+9% +$189K 0.08% 224
2020
Q1 		$925K Sell
68,600
-1,793
-3% -$30.2K 0.04% 447
2019
Q4 		$1.49M Buy
70,393
+17,845
+34% +$315K 0.05% 391
2019
Q3 		$697K Buy
52,548
+7,677
+17% +$113K 0.02% 605
2019
Q2 		$622K Sell
44,871
-4,506
-9% -$67.8K 0.02% 624
2019
Q1 		$949K Buy
+49,377
New +$796K 0.04% 473

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return